[The role of neuraminidase in the development of a dermonecrotic effect when Vibrio cholerae antigens are used].
Isupov
I V
IV
Sageeva
O F
OF
Eliseev
Iu Iu
IuIu
Adamov
A K
AK
Saiapina
L V
LV
Kovalenko
N M
NM
Luk'ianova
O I
OI
D000251:Adenosine Triphosphatases / Q000008:administration & dosage / Q000633:toxicity; D000818:Animals; D002772:Cholera Toxin / Q000037:antagonists & inhibitors; D003885:Dermotoxins / Q000008:administration & dosage / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D007271:Injections, Intradermal; D009336:Necrosis; D009439:Neuraminidase / Q000008:administration & dosage / Q000633:toxicity*; D019081:O Antigens; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000633:toxicity*; D011817:Rabbits; D012867:Skin / Q000187:drug effects* / Q000473:pathology*; D013997:Time Factors; D014121:Toxoids / Q000008:administration & dosage / Q000633:toxicity; D014734:Vibrio cholerae / Q000201:enzymology* / Q000276:immunology*
D003885:Dermotoxins; D019081:O Antigens; D011135:Polysaccharides, Bacterial; D014121:Toxoids; D002772:Cholera Toxin; D009439:Neuraminidase; D000251:Adenosine Triphosphatases